“Molecular
Genetics of the Dystroglycan Complex and Muscular Dystrophy.” McGill
University, 10th F.L. McNaughton Lecturer, Montréal Neurological
Institute and Hospital, Montréal, Canada, December 5-7, 1994. |
“Dystroglycan:
A Novel Laminin Receptor and Its Role in Muscular Dystrophy.” University
of Iowa, College of Medicine, Department of Neurology, Update in Neuromuscular
Disease, Iowa City, Iowa, November 5-6, 1994. |
“Identification and Functional
Characterization of Subunit Interaction Sites in Voltage-Gated Calcium
Channels.” International Symposium, Molecular and Cell Biology of
Ion Channels, Cancun, Mexico, September 30-October 3, 1994. |
“Dystroglycan:
A Novel Laminin/Agrin Receptor Linking Extracellular Matrix to Cytoskeleton.”
Miles, Inc., New Haven, CT, September 27-29, 1994. |
“Dystroglycan: A Novel
Laminin Binding Protein and Its Role in Muscular Dystrophy.” University
of Arizona, Tucson, Arizona, September 22, 1994. |
“Role
of Dystroglycan and Dystrophin-Associated Glycoproteins in Muscular Dystrophy.”
Vanderbilt University Medical Center, MSTP Program, Nashville, Tennessee,
November 2, 1994. |
“Neuronal Ca2+ Channel Structure and Subunit Interaction Sites.” Vanderbilt University
Medical Center, 1994 Lamson Memorial Lecturer, Department of Pharmacology,
November 1, 1994. |
“Dystroglycan:
A Novel Merosin Receptor and Its Role in the Molecular Pathogenesis of
Muscular Dystrophy.” and “Deficiency of Adhalin in the Cardiomyopathic
Hamster: A Possible Model for Autosomal Recessive Muscular Dystrophy and
Cardiomyopathy” VIII International Congress on Neuromuscular Diseases,
Kyoto, Japan, July 8-16, 1994. |
“Dystroglycan: A Novel
Laminin Binding Protein and Its Relationship to Muscular Dystrophy.”
Neuromuscular and EMG Conference, Iowa City, Iowa, June 24, 1994. |
“Dystroglycan:
A Novel Laminin Binding Glycoprotein of Muscle.” Gordon Research
Conference, Basement Membranes, Wolfeboro, New Hampshire, June 14, 1994. |
“Dystroglycan, A Novel
Laminin Receptor and Its Role in Muscular Dystrophy.” University
of Michigan, MAC Symposium, Detroit, Michigan, May 27, 1994. |
“Identification
and Functional Characterization of Subunit Interaction Sites In Voltage-Gated
Ca2+ Channels.” Parke-Davis Biotechnology, Ann Arbor,
Michigan, May 26, 1994. |
“Identification and Functional
Characterization of Subunit Interaction Sites In Voltage-Gated Ca2+ Channels.” University of Michigan, Department of Physiology, Detroit,
Michigan, May 25, 1994. |
“Dystroglycan,
A Novel Laminin Receptor and its Role in Muscular Dystrophy.” American
Society for Biochemistry and Molecular Biology, Amgen Award Presentation,
Washington, D.C., May 24, 1994. |
“Identification of Subunit
Interaction Sites Within Ca2+ Channels.” University of
Minnesota, Minneapolis, Minnesota, May 19, 1994. |
“Dystroglycan:
A Novel Laminin Binding Protein and Its Role in Muscular Dystrophy.”
University of Minnesota, Minneapolis, Minnesota, May 18, 1994. |
“Dystroglycan: A Novel
Merosin Binding Protein and its Role in Muscular Dystrophy.” I.N.S.E.R.M.,
Paris, France, April 27, 1994. |
“Calcium
Channel b-Subunit
Binds to a Conserved Motif in the I-II Cytoplasmic Linker of the
a1
Subunit.” Bayer AG, International Albrecht Fleckenstein Award 1994
Presentation, Leverkusen, Germany, April 25, 1994. |
“Dystrophin, Dystrophin-Associated
Glycoproteins and Extracellular Matrix Protein.” European Neuro
Muscular Center, Congenital Muscular Dystrophy International Workshop,
The Netherlands, April 22-24, 1994. |
“Ca2+ Channel Structure and Subunit Interaction Sites.” Mayo Clinic, Rochester,
Minnesota, April 13, 1994. |
“Dystroglycan: A Novel
Laminin Binding Protein and Its Relationship to Muscular Dystrophy.”
Mayo Clinic, Rochester, Minnesota, April 12, 1994. |
“Voltage-Sensitive
Ca2+ Channels: Structure and Subunit Interaction Sites.”
University of Chicago, Neurobiology, Chicago, Illinois, February 17, 1994. |
“Voltage-Sensitive Ca2+ Channels: Structure and Subunit Interaction Sites.” Massachusetts
General Hospital, Neurosurgery, Boston, Massachusetts, January 12-13,
1994. |
“Dystroglycan:
A Novel Laminin-Binding Protein and Its Role in Muscular Dystrophy.”
Stanford University, MSTP Program, Stanford, California, November 18,
1993. |
“Voltage-Sensitive Ca2+ Channels: Structure and Subunit Interaction Sites.” University Medical
Center, Stanford, California, November 17, 1993. |
“Structural
and functional characterization of N-type Ca2+ channels.”
Calcium Channels and Neuronal Signaling Meeting, Washington, D.C., November
4-9, 1993. |
“Molecular Pathogenesis
of Duchenne Muscular Dystrophy.” Muscular Dystrophy Association
Western Iowa Chapter, Midwest Seminar, Des Moines, Iowa, October 2, 1993. |
“Possible
Role of the Dystrophin-Glycoprotein Complex in Cardiomyopathy.”
University of California, San Francisco, Program of Excellence in Molecular
Biology Seminar, San Francisco, California, September 26-27, 1993. |
“Molecular Pathogenesis
of Duchenne Muscular Dystrophy.” Muscular Dystrophy Association
Awareness Seminar, Moline, Illinois, September 25, 1993. |
“Possible
Role of Dystrophin-Glycoprotein Complex in Cardiomyopathy.” American
Heart Association, Molecular Biology of the Normal, Hypertrophied and
Failing Heart, Pacific Grove, California, August 4-8, 1993. |
“Dystroglycan, A Novel
Laminin Binding Protein and Its Role in Muscular Dystrophy.” Gordon
Conference, Cell Contact and Adhesion, Andover, New Hampshire, July 1,
1993. |
“Purification
of w-Conotoxin
Sensitive Ca2+ Channels.” Vanderbilt University, Department
of Molecular Physiology & Biophysics, Nashville, Tennessee, June 17,
1993 |
“Molecular Pathogenesis
of Duchenne Muscular Dystrophy.” Cornell University Medical College,
The Department of Cell Biology and Anatomy, The Nina W. Werblow Lecture,
New York, New York, May 20, 1993 |
“Dystroglycan
and Molecular Pathogenesis of Duchenne Muscular Dystrophy.” National
Institutes of Health, Bethesda, Maryland, May 29, 1993. |
“Dystroglycan: A Novel
Laminin Receptor.” Howard Hughes Medical Institute Annual Scientific
Meeting, Receptors and Receptor Function in Health and Disease, Chevy
Chase, Maryland, May 16-19, 1993. |
“Dystroglycan
and Molecular Pathogenesis of Duchenne Muscular Dystrophy.” The
University of Texas, Southwestern Medical Center at Dallas, University
of Texas Lecture Series, Dallas, Texas, April 28, 1993. |
“Dystrophin and Utrophin:
Functional and Comparative Aspects.” Cold Spring Harbor, Gene Reactivation
as a Therapeutic Strategy for Duchenne and Becker Muscular Dystrophies,
Session II: Regulation of Dystrophin and Dystrophin-Related Protein Gene
Expression, New York, New York, April 26, 1993. |
“Dystroglycan
and Molecular Pathogenesis of Duchenne's Muscular Dystrophy.” Massachusetts
General Hospital, February 23, 1993, Boston, Massachusetts |
“Purification and Characterization
of Conotoxin-Sensitive Calcium Channels.” Harvard Medical School,
Boston, Massachusetts, February 22, 1993. |
“Dystroglycan:
A Novel Laminin Binding Protein and Its Role in Muscular Dystrophy.”
Yale University, New Haven, CT, December 3, 1992 |
“Purification and Characterization
of the w-Conotoxin-Sensitive
Calcium Channel.” Miles Laboratories, Inc., West Haven, CT, December
3, 1992. |
“Intracellular
Calcium Release Channels: Structure, Function and CNS Distribution.”
Society for Neuroscience, New Waves in Cell Calcium, Anaheim, California,
October 27, 1992. |
“Purification and Characterization
of the w-Conotoxin
Sensitive Calcium Channel from Rabbit Brain.” Bayer AG Seminar,
Wuppertal, Germany, September 23, 1992. |
“Dystroglycan:
High Affinity Laminin Receptor in Skeletal Muscle.” XXI European
Muscle Congress Meeting, Ion Channels and Other Membrane-Associated Proteins,
Bielefeld, Germany, September 22, 1992. |
“Molecular Basis for
Autosomal Recessive Muscular Dystrophy: A 50 kDa Dystrophin-Associated
Glycoprotein Deficiency.” Howard Hughes Medical Institute Annual
Scientific Meeting, Genetic Disorders and the Search for Genetic Factors
in Disease, Bethesda, Maryland, September 13-16, 1992. |
“Molecular
Pathogenesis of Duchenne Muscular Dystrophy.” University of Iowa
and University of Minnesota, Medical Scientist Training Program Retreat,
Lake Okoboji, Iowa, August 29, 1992. |
“Laminin Binding Properties
of Dystroglycan and its Role in Muscular Dystrophy.” University
of Iowa, Physiology and Biophysics Workshop, August 26, 1992. |
“Purification
and Characterization of the w-Conotoxin
Sensitive Calcium Channel from Rabbit Brain.” Neurex Corporation
Seminar, Menlo Park, California, August 17, 1992 |
“The Role of the Dystrophin-Glycoprotein
Complex in the Transmembrane Linkage Between Laminin and Actin.”
Cold Spring Harbor Laboratory, Brain Development and Function, Cold Spring
Harbor, New York, August 7, 1992. |
Chairperson
and Organizer, FASEB Conference on Calcium and Cell Function, Vermont
Academy, Saxton Rivers, VT, July 5-10, 1992. |
“Dystroglycan: Structure,
Function and Its Role In the Molecular Pathogenesis of Duchenne Muscular
Dystrophy.” Institut de Pathologie Moleculaire, Service de Biochimie
Genetique, Pavillon Cassini, Paris, France, May 26, 1992. |
“Dystroglycan:
Structure, Function and Its Role In the Molecular Pathogenesis of Duchenne
Muscular Dystrophy.” I.N.S.E.R.M., Paris, France, May 25, 1992. |
“The Brain Ryanodine
Receptor: A Caffeine-Sensitive Calcium Channels From Excitable Cells.”
Calcium Club, Milan, Italy, May 22, 1992. |
“Molecular
Components of Voltage-Sensitive Calcium Channels From Excitable Cells.”
The Emilio Trabucchi Foundation, Milan, Italy, May 21, 1992. |
“Molecular Characterization
of the Dystrophin-Associated Glycoproteins.” Iowa State University,
Department of Biochemistry and Biophysics, April 23, 1992. |
“Molecular
Pathogenesis of Duchenne Muscular Dystrophy.” David Mahoney Institute
of Neurological Sciences, University of Pennsylvania, The School of Medicine,
November 20, 1991. |
“Biochemistry of the w-Conopeptide
Receptor.” Society for Neuroscience, Satellite Symposium, Neurex
Corporation, November 10, 1991. |
“Molecular
Characterization of the Dystrophin-Associated Glycoproteins.” 8th
International Congress of Human Genetics, Workshop Title: “Molecular
and Cellular Biology of Duchenne Muscular Dystrophy and Becker Muscular
Dystrophy,” Washington, DC, October 6-11, 1991. |
“Loss of Dystrophin-Associated
Protein in Dystrophic Muscle.” Muscular Dystrophy Association, Gene
Therapy Conference, Tucson, Arizona, September 27, 1991. |
“Neuronal
Ryanodine Receptor: A Caffeine-Sensitive Calcium Release Channel.”
Howard Hughes Medical Institute Annual Scientific Meeting, Bethesda, Maryland,
Signal Transduction and Its Consequences, September 22-25, 1991 |
“Ca2+ Channels
and Dystrophin-Glycoprotein Complex.” Hopital Cantonal Universitaire
de Geneve, Geneva, Switzerland, July 8, 1991. |
“Dystrophin-Glycoprotein
Complex.” Charing Cross and Westminster Medical School, London,
England, July 5, 1991. |
“Muscle and Neuronal
Ca Channels: Their Properties, Distribution and Structural Features.”
ICI Agrochemicals, July 4, 1991. |
“The
Dystrophin-Glycoprotein Complex.” Institute of Molecular Medicine,
John Radcliffe Hospital, Oxford, England, July 3, 1991. |
“Dystrophin-Associated
Glycoproteins: Structure and Function.” 4th National Meeting on
Neuromuscular Diseases, Montpellier, France, June 24-28, 1991. |
“Dystrophin-Linked
Glycoproteins in Duchenne Muscular Dystrophy.” FASEB Conferences,
American Physiological Society 1991 Annual Spring Meeting, Symposium on
“Cellular and Molecular Aspects of Muscle Disease,” Atlanta,
Georgia, April 21-26, 1991 |
“Functional Aspects of
Dystrophin.” Annual Biophysical Society Meeting, Contractility Subgroup
Symposium, San Francisco, California, February 24, 1991. |
“The
Dystrophin-Glycoprotein Complex: Identification and Biochemical Characterization.”
Keystone Symposia on Molecular and Cellular Biology of “Gene Expression
in Neuromuscular Development,” Keystone, Colorado, January 24-30,
1991. |
“Dystrophin-Glycoprotein
Complex and Molecular Pathogenesis of Duchenne Muscular Dystrophy.”
Colorado State University, Department of Physiology, Fort Collins, Colorado,
November 26, 1990. |
“Dystrophin-Glycoprotein
Complex and Molecular Pathogenesis of Duchenne Muscular Dystrophy.”
University of Wisconsin-Madison, Department of Physiology, Madison, Wisconsin,
October 15, 1990. |
“Deficiency of a Dystrophin-Associated
Glycoprotein in Duchenne Muscular Dystrophy.” VII International
Congress on Neuromuscular Diseases, Surprise Box Session, Munich, West
Germany, September 16-21, 1990. |
“The
Dystrophin-Glycoprotein Complex: Identification and Biochemical Characterization.”
National Cardiovascular Center Research Institute, Department of Molecular
Physiology, Osaka, Japan, July 23, 1990. |
“The Dystrophin-Glycoprotein
Complex: Identification and Biochemical Characterization.” Osaka
University, First Department of Medicine, Division of Cardiology, Osaka,
Japan, July 21, 1990. |
“The
Dystrophin-Glycoprotein Complex: Identification and Biochemical Characterization.”
Kyoto University, Department of Medicinal Chemistry, Kyoto, Japan, July
20, 1990. |
“The Dystrophin-Glycoprotein
Complex: Identification and Biochemical Characterization.” Uehara
Memorial Foundation Symposium on Frontiers of Muscle Research, Tokyo,
Japan, July 16-19, 1990. |
“Identification
and Characterization of the Dystrophin-Glycoprotein Complex in Normal
and Dystrophic Muscle.” University of California, San Francisco,
Department of Physiology, May 16, 1990. |
“Structure of Calcium
Channels.” AHA Conference on Structure & Function of Ion Channels
in the Heart and Vascular System, Chicago, Illinois, May 8-11, 1990. |
“Molecular
Pathogenesis of Muscular Dystrophy.” Johns Hopkins University School
of Medicine, Neuroscience Department, March 29, 1990. |
“Molecular Pathogenesis
of Muscular Dystrophy.” Howard Hughes Medical Institute Annual Scientific
Meeting, Molecular Basis of Human Diseases and Animal Models of Human
Disease, Bethesda, Maryland, February 11-14, 1990. |
|